Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical)

v3.20.2
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Dilutive Common Stock Equivalents (Details) (Parenthetical) - Convertible Notes Payable One [Member] - USD ($)
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock issuable upon conversion, shares 5,762,056 8,050,000
Common stock issuable upon conversion $ 1,152,411 $ 805,000
Common stock issuable upon conversion, price per share $ 0.20 $ 0.10
Beneficial ownership limitations percentage 9.99% 4.99%